X4 Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.

About XFOR

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. 

CEO
Paula S. Ragan, PhD
CEOPaula S. Ragan, PhD
Employees
143
Employees143
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2010
Founded2010
Employees
143
Employees143

XFOR Key Statistics

Market cap
369.42M
Market cap369.42M
Price-Earnings ratio
-0.42
Price-Earnings ratio-0.42
Dividend yield
Dividend yield
Average volume
592.25K
Average volume592.25K
High today
$4.27
High today$4.27
Low today
$3.64
Low today$3.64
Open price
$3.75
Open price$3.75
Volume
617.92K
Volume617.92K
52 Week high
$9.70
52 Week high$9.70
52 Week low
$1.35
52 Week low$1.35

Stock Snapshot

X4 Pharmaceuticals(XFOR) stock is priced at $4.25, giving the company a market capitalization of 369.42M. It carries a P/E multiple of -0.42.

On 2026-03-17, X4 Pharmaceuticals(XFOR) stock traded between a low of $3.64 and a high of $4.27. Shares are currently priced at $4.25, which is +16.8% above the low and -0.5% below the high.

The X4 Pharmaceuticals(XFOR)'s current trading volume is 617.92K, compared to an average daily volume of 592.25K.

During the past year, X4 Pharmaceuticals(XFOR) stock moved between $1.35 at its lowest and $9.70 at its peak.

During the past year, X4 Pharmaceuticals(XFOR) stock moved between $1.35 at its lowest and $9.70 at its peak.

XFOR News

Nasdaq 12h
X4 Pharmaceuticals Reports Q4 Loss, Tops Revenue Estimates

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $...

X4 Pharmaceuticals Reports Q4 Loss, Tops Revenue Estimates

People also own

Based on the portfolios of people who own XFOR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.